For more information about the HoLEP Procedure, click here.
TEMPLE, Texas – In mid-October, Baylor Scott & White Medical Center – Temple conducted its 1000th holmium laser enucleation of the prostate (HoLEP), a minimally invasive procedure that can address benign prostatic hyperplasia (BPH). BPH can prevent the bladder from emptying properly and could lead to kidney damage or failure. It also impacts quality of life in about one third of men older than 50 years old.
The 1000th procedure marks a major milestone in the program’s five-year history. Since September 2015, Baylor Scott & White – Temple has averaged almost 200 HoLEP procedures a year, one of the highest volumes among U.S. medical centers and the highest in Texas.
“We continue to see how this procedure changes the lives of men with an enlarged prostate,” said Marawan El Tayeb, MD, PhD, a urologist who specializes in benign prostatic enlargement and kidney stones on the medical staff at Baylor Scott & White – Temple. “We feel fortunate to help improve our patients’ quality of life with this procedure.”
The hospital’s program draws patients from throughout the region, including from Houston, San Antonio, Dallas, Conroe, Bryan, Lubbock, Abilene, and from as far as Oklahoma, New Mexico, and Illinois. After the procedure, 99% of patients stayed in the hospital less than 24 hours. Patients experienced a success rate of relieving urinary retention of 99.7%, an incontinence rate of less than 1%, a blood transfusion rate less than 2%, and a complication rate of less than 2%.
“Our team’s commitment to providing quality care for men through this life-changing procedure is truly remarkable,” said Erin Bird, MD, director for the division of urology at Baylor Scott & White – Temple. “We know this procedure is helping our patients recover, allowing them to enjoy activities that are most important to them.”
Committed to innovative research, training the next generation
The division of urology at Baylor Scott & White – Temple is staffed by board-certified urologists on the medical staff who provide advanced services for evaluation, consultation and medical and surgical treatment of urologic disorders. The team is also involved in research and ongoing clinical trials to bring new treatments to the forefront. In addition to conducting clinical research, the program provides training for urology residents to make this procedure more readily available in the United States.
The program continues to grow through research collaboration with other medical institutions to share best practices to improve outcomes. For more information, visit HoLEP at Baylor Scott & White.
Physicians provide clinical services as members of the medical staff at one of Baylor Scott & White Health’s subsidiary, community or affiliated medical centers and do not provide clinical services as employees or agents of those medical centers or Baylor Scott & White Health.
# # #
About Baylor Scott & White Health
As the largest not-for-profit health system in the state of Texas, Baylor Scott & White promotes the health and well-being of every individual, family and community it serves. It is committed to making quality care more accessible, convenient and affordable through its integrated delivery network, which includes the Baylor Scott & White Health Plan, Baylor Scott & White Research Institute, the Baylor Scott & White Quality Alliance and its leading digital health platform – MyBSWHealth. Through 51 hospitals and more than 1,200 access points, including flagship academic medical centers in Dallas, Fort Worth and Temple, the system offers the full continuum of care, from primary to award-winning specialty care. Founded as a Christian ministry of healing more than a century ago, Baylor Scott & White today serves more than three million Texans. For more information, visit: BSWHealth.com